ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000764.1|Exopolysaccharide_1 # 3 # 455 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.362	BGC0000764.1|Exopolysaccharide_1 	3	455	+	Loose	700	29.261	ADC-208	26.76	3006377	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	TTTCAAAAGCAAATTCGTAAAGTGATAGAAGAGAAAATAAAAAACGGAAACGAAATTTTTCAACCAATTGGTAAAAAGAAGTCACCAAAAAAAGCTAAAAATCCTGCAAGAGCCTATCGTCAAGAGGTTAAGGACTCTATTATTGACGAAGAGCTGTTTGACTACTTGCGGGAACAATCTAAGAAAGATACAATTGAACGTTTTAAGAGCCGCTCAGATTACGATAGCGAAGCTTTGGCCATGAACGCTGACTTTCAGGAGTTTGTTGAAAAACAGACGTTCCCAGAAGAAGTAGGACGCTGGGAGGGTTTGACTGAAGCTCATGATAGAGTAAAAAAAAAAGAGCAAATATCATTTCAGAAGCACTGTTTGCTTACTTGTCTTCTAATCGATTTTCTTATTCAACAAAAGAAATTTCATCTTTCTTACCCATTTTTGACCCTGTGTTCATAA	FQKQIRKVIEEKIKNGNEIFQPIGKKKSPKKAKNPARAYRQEVKDSIIDEELFDYLREQSKKDTIERFKSRSDYDSEALAMNADFQEFVEKQTFPEEVGRWEGLTEAHDRVKKKEQISFQKHCLLTCLLIDFLIQQKKFHLSYPFLTLCS	MQFKKISCLLLPPLFIFSSSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGGYAKTKGTISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKEWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYINLPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	39.16	gnl|BL_ORD_ID|3206|hsp_num:0	4273			411	615	
BGC0000764.1|Exopolysaccharide_2 # 446 # 625 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.322	BGC0000764.1|Exopolysaccharide_2 	446	625	+	Loose	500	21.1718	APH(6)-Id	35.0	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	GTGTTCATAAGGGAAAAACTATTTTTTGAAAATTTTGAATTAGATCTAAAAGGGTTAGTGAGTGACATGAATCATTATGATAGCTTATTCGAATGCCAAGGAGATTTATCGGGGAAGGATCGGCAACTTGAGGATAAACTTAAGGATTGGAAAAGTTATGCTTGGTTAAAAAATAAATGA	MFIREKLFFENFELDLKGLVSDMNHYDSLFECQGDLSGKDRQLEDKLKDWKSYAWLKNK	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	21.22	gnl|BL_ORD_ID|950|hsp_num:0	1031			492	552	streptomycin
BGC0000764.1|Exopolysaccharide_3 # 724 # 1146 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.340	BGC0000764.1|Exopolysaccharide_3 	724	1146	-	Loose	475	29.261	GMB-1	26.23	3006889	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	GMB beta-lactamase	GTGATTGGCTATGAAATCTCTAACCAACCAACCTATCAAGCTATTGCGACAGCACTTCAGGAGGCTTTAGAATTGACTTCTGATTGTCTCTATCGTCGTACTTTCCACTCTGACCAAGGGTGGGCATATCAGATGAAAAACTATGTCTTTAAGCTCAAATCACAAAAAATAATCCAATCTATGAGTCGCAAAGGTAACTGTCATGATAATTCAGTCATGGAGAACTTCTTTGGCTTGCTTAAACAAGAAATCTACTATGGTCATGTTTTCAATTCATTTGAAGAACTTGAACAAGCGATTACTAAATGGATTCACTATTACAACACGAAACGAATTAAGAAAAAATTGAACTGGATGAGTCAATCCAAATCGTTTAACTTATTCAAAATAACAAAAAAAAGACAAGAAATTATTCTTGTCTAA	MIGYEISNQPTYQAIATALQEALELTSDCLYRRTFHSDQGWAYQMKNYVFKLKSQKIIQSMSRKGNCHDNSVMENFFGLLKQEIYYGHVFNSFEELEQAITKWIHYYNTKRIKKKLNWMSQSKSFNLFKITKKRQEIILV	MLNFVFALFTAFTAFSAFALDQKAFDEQFAVKELAKDTYQVTDKFYHDSNVLVARMPDGTVVIASSPFETVGAQLMMDWIKEKWDPKRIVAVNTHFHSDGTGGNEAYKQAGAEIWASDLTWRLHRQSTKKDQQALADGFKSKPELRDRILKRKTVHANRTFKSKEGKIFDFGGEKVELIFPGEGHTSDNSVVYLPQRKVLFGGCLIRSAKHDIGYLGDAVVKPWAETVRNVQKLKPEIVIPGHGPVGGPELLTRTIDLAEKEAAKGTTKN	51.85	gnl|BL_ORD_ID|3562|hsp_num:0	4631			396	576	
BGC0000764.1|Exopolysaccharide_4 # 1143 # 1478 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.390	BGC0000764.1|Exopolysaccharide_4 	1143	1478	-	Loose	500	23.8682	APH(2'')-If	27.66	3004191	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGCTTGAAATACGTCAAGNACACACTAATGCAGGGTATCGTCCAATGGTTGAGCTATTAAACAACGTGGAATTTATGTTAATCACAAGAAGGTTCAGCGGCTTGATGAAAAAACTTGGGCTTCGTGTGACTACTTTTTGGCATAAATCTCGTAAATATAACTCTTACAAAGGTAAAGTTGGGACTGTGGCTAAGAACAAGCTCCACAGACGATTTAACACTTCTGTACCACATCAAAAGATACGACAGACACCACTGAGTTCAAATATTACGATAAAGGGGTTCAAAAGAAGCTTTATCTCAACCCCTATCTTGACCTTTTCAACAACGAAGTGA	MLEIRQXHTNAGYRPMVELLNNVEFMLITRRFSGLMKKLGLRVTTFWHKSRKYNSYKGKVGTVAKNKLHRRFNTSVPHQKIRQTPLSSNITIKGFKRSFISTPILTFSTTK	MDIKKIIEEKCNIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFLNKKLNTNIKIPNIEYSYISEELSILGYKEIKGTFLTPEIYFALSKEKQELLKQDIAMFLRQMHDLDYSEISSYTIDNKQNVLEEYQLLKETIYDSLTDIEKQYVEEFMQRLNSTTIFDGKKCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILRLYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDEKLRK	37.37	gnl|BL_ORD_ID|2424|hsp_num:0	2837			177	315	dibekacin; sisomicin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000764.1|Exopolysaccharide_6 # 2590 # 2907 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.302	BGC0000764.1|Exopolysaccharide_6 	2590	2907	+	Loose	1500	23.483	rphA	45.0	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAATGATTTATTTTACCATCGTCTAAAGGAACTAGTTGAAGCAAGTGGTAAATCTGCAAATCAAATAGAAAGGGAATTGGGTTACCCTAGAAATTCTTTGAATAATTATAAGTTGGGAGGAGAACCCTCTGGGACAAGATTAATAGGACTATCAGAGTATTTTAATGTGTCTCCAAAATATCTGATGGGTATAATTGATGAGCCTAATGACAGTTCTGCAATTAATCTTTTTAAAACTCTAACTCAAGAAGAGAAAAAAGAAATGTTTATAATTTGTCAAAAATGGCTTTTTTTAGAATATCAAATAGAGTTATAA	MNDLFYHRLKELVEASGKSANQIERELGYPRNSLNNYKLGGEPSGTRLIGLSEYFNVSPKYLMGIIDEPNDSSAINLFKTLTQEEKKEMFIICQKWLFLEYQIEL	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	12.14	gnl|BL_ORD_ID|890|hsp_num:0	910			1302	1362	rifampin; rifaximin; rifabutin; rifapentine
BGC0000764.1|Exopolysaccharide_7 # 2941 # 3708 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.302	BGC0000764.1|Exopolysaccharide_7 	2941	3708	+	Loose	890	29.261	OprA	21.71	3003039	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATGAAAAAAGGAATTTTTGTAATTACTATAGTGATATCTATAGCATTTATAATTGGAGGTTTTTATAGTTATAATTCTAGGATAAGTAATCTTTCAAAAGCTGATAAAGGAAAAGAAGTTGTAAAAAATAGCAGTGAAAAAAATCAGATAGACCTTACCTATAAAAAGTATTATAAAAATTTACCAAAATCAGTTCAAAATAAAATAGATGATATTTCATCCAAAAATAAAGAAGTTACTTTAACTTGTATTTGGCAATCTGATTCAGTTATTTCTGAACAATTTCAACAAAACTTACAAAAATATTATGGAAATAAGTTTTGGAACATCAAAAATATCACTTACAATGGCGAAACTAGTGAACAATTATTGGCTGAAAAAGTTGAAAACCAAGTATTAGCCACTAATCCTGATGTTGTTTTATATGAAGCTCCACTTTTTAATGATAACCAAAACATTGAAGCAACAGCCTCACTGACTAGTAATGAGCAACTTATAACAAATTTGGCTAGTGCAGGAGCGGAGGTAATAGTTCAACCCTCTCCACCGATCTATGGTGGTGTTGTGTACCCCGTACAAGAAGAACAATTTAAACAATCTTTATCTACAAAGTATCCCTATATAGACTACTGGGCTAGTTACCCAGACAAAAATTCTGATGAAATGAAGGGACTGTTTTCTGATGATGGAGTATATAGAACATTAAATGCTTCGGGGAATAAGGTTTGGCTAGATTATATTACTAAATATTTTACAGCAAACTAA	MMKKGIFVITIVISIAFIIGGFYSYNSRISNLSKADKGKEVVKNSSEKNQIDLTYKKYYKNLPKSVQNKIDDISSKNKEVTLTCIWQSDSVISEQFQQNLQKYYGNKFWNIKNITYNGETSEQLLAEKVENQVLATNPDVVLYEAPLFNDNQNIEATASLTSNEQLITNLASAGAEVIVQPSPPIYGGVVYPVQEEQFKQSLSTKYPYIDYWASYPDKNSDEMKGLFSDDGVYRTLNASGNKVWLDYITKYFTAN	MPLSKLSASSLALCLGLLGACSLAPRYQRPEAPIPTTYPAVPASQQAGDRARLDDWQQQFTDPVLRQMIGQALEHNRNLRVAALRIEEARALYGVQASERLPTLEASGRYERERMRGETREAGEVEQRYRVAAGISAFELDFFGRVKNLGDAALADYLASEEAQRSARIALIAEVAGGYVQERALYAQQRLAERTLHARENGLALVRKRYAAGMSTRIDLRSEEMLVESARATHAALVRERSQAVSGLQLLLGDFTGDWQDSQLDLEHLQLQPLPAGLPSELLARRPDIRQAEQQLRAANANIGAARAAFFPSLRLSTDLGSASSGLHGLFRGGSRVWTFSPQMTLPIFDGGRNRANLDLAEVRKDIAVNRYEESIQVAFREVADALSAGDQLELQLRAQRAVRDADRERLQLVRKRYAKGVANYLEMLDAQRSLFDSEQQLIHLRGLRLNNGVALYRALGGGWSQG	54.60	gnl|BL_ORD_ID|1503|hsp_num:0	1570			591	969	erythromycin; amikacin; gentamicin C; ciprofloxacin; tetracycline; tobramycin; meropenem; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000764.1|Exopolysaccharide_8 # 3748 # 4527 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.338	BGC0000764.1|Exopolysaccharide_8 	3748	4527	+	Loose	1900	25.0238	MexI	35.48	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAGGAAACACAGGAACAAACGATTGATTTAAGAGGGATTTTTAAAATTATTCGCAAAAGGTTAGGTTTAATATTATTTAGTGCTTTAATAGTCACAATATTAGGGAGCATCTACACATTTTTTATAGCCTCCCCAGTTTACACAGCCTCAACTCAACTTGTCGTTAAACTACCAAATTCGGATAATTCAGCAGCCTACGCTGGACAAGTGACCGGGAATATTCAAATGGCGAACACAATTAACCAAGTTATTGTTAGTCCAGTCATTTTAGATAAAGTTCAAAGTAATTTAAATCTATCTGATGATTCTTTCCAAAAACAAGTTACAGCAGCAAATCAAACAAATTCACAAGTTATTACGCTTACTGTTAAATATTCTAATCCTTACATTGCACAAAAGATTGCAGACGAGACTGCTAAAATATTTAGTTCAGACGCAGCGAAACTATTGAATGTTACTAACGTTAATATTCTATCCAAAGCAAAAGCTCAAACAACACCCATTAGTCCTAAACCTAAATTGTATTTAGCAATATCTGTTATAGCCGGATTAGTTTTAGGTTTAGCCATTGCTTTATTGAAGGAATTGTTTGATAACAAAATTAATAAAGAAGAAGATATTGAAGCTCTGGGACTCACGGTTCTTGGTGTAACAACCTATGCTCAAATGAGTGATTTTAATAAGAATACGAATAAAAATGGCACGCAATCGGGAACTAAGTCAAGTCCGCCTAGCGACCATGAAGTAAATAGATCATCAAAAAGGAATAAAAGATAG	MQETQEQTIDLRGIFKIIRKRLGLILFSALIVTILGSIYTFFIASPVYTASTQLVVKLPNSDNSAAYAGQVTGNIQMANTINQVIVSPVILDKVQSNLNLSDDSFQKQVTAANQTNSQVITLTVKYSNPYIAQKIADETAKIFSSDAAKLLNVTNVNILSKAKAQTTPISPKPKLYLAISVIAGLVLGLAIALLKELFDNKINKEEDIEALGLTVLGVTTYAQMSDFNKNTNKNGTQSGTKSSPPSDHEVNRSSKRNKR	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	25.17	gnl|BL_ORD_ID|4683|hsp_num:0	1647			2919	3003	acriflavine; tetracycline; norfloxacin
BGC0000764.1|Exopolysaccharide_9 # 4537 # 5232 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.359	BGC0000764.1|Exopolysaccharide_9 	4537	5232	+	Loose	550	25.7942	KPC-21	45.83	3003145	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGGCTAAAAATAAAAGAAGCATAGACAACAATCGTTATATTATTACCAGTGTCAATCCTCAATCGCCTATTTCCGAACAATATCGTACGATTCGTACGACCATTGATTTTAAAATGGCGGATCAAGGGATTAAAAGTTTTCTAGTAACATCTTCAGAAGCAGCTGCAGGTAAATCAAACGGGAGTGCTAATCTAGCTGTTGCTTTTGCACAACAAGGTAAAAAAGTACTTTTAATTGATGGCGATCTTCGTAAACCGACTGTTAACATTACTTTTAAAGTACAAAATAGAGTAGGATTAACCAATATTTTAATGCATCAATCTTCGATTGAAGATGCCATACAAGGGACAAGACTTTCTGAAAATCTTACAATAATTACCTCTGGTCCAATTCCACCTAATCCATCGGAATTATTAGCATCTAGTGCAATGAAGAATTTGATTGACTCTGTGTCCGATTCCTTTGATGTTGTTTTGATTGATGCTCCACCTCTCTATGCAGTTACTGATGCTCAAATTTTGAGTGTTTATGTAGGAGGAGTGGTTCTTGTTGTACGTGCCTATGAAACAAAAAAAGAGAGTTTAGCAAAAGCAAAAAAAATACTGGAACAAGTTAATGCAAATATATTAGGAGTTGTTTTGCATGGGGTAGACTCTTCTGAGTCACCGTCGTATTACTACTACGGAGTAGAGTAA	MAKNKRSIDNNRYIITSVNPQSPISEQYRTIRTTIDFKMADQGIKSFLVTSSEAAAGKSNGSANLAVAFAQQGKKVLLIDGDLRKPTVNITFKVQNRVGLTNILMHQSSIEDAIQGTRLSENLTIITSGPIPPNPSELLASSAMKNLIDSVSDSFDVVLIDAPPLYAVTDAQILSVYVGGVVLVVRAYETKKESLAKAKKILEQVNANILGVVLHGVDSSESPSYYYYGVE	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPRSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	78.84	gnl|BL_ORD_ID|3650|hsp_num:0	4719			282	354	
BGC0000764.1|Exopolysaccharide_10 # 5287 # 6051 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.333	BGC0000764.1|Exopolysaccharide_10 	5287	6051	+	Loose	200	27.7202	vanT gene in vanN cluster	23.08	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGATTGATATTCATTGCCATATTTTACCGGGGATAGATGATGGAGCTAAAACTTCTGGAGATACTCTGACAATGCTGAAATCAGCAATTGATGAAGGGATAACAACTATCACTGCAACTCCTCATCATAATCCTCAATTTAATAATGAATCACCGCTTATTTTGAAAAAAGTTAAGGAAGTTCAAAATATCATTGACGAACATCAATTACCAATTGAAGTTTTACCCGGACAAGAGGTGAGAATATATGGTGATTTATTAAAAGAATTTTCTGAAGGGAAGTTACTGACAGCAGCGGGCACTTCAAGTTATATATTGATTGAATTTCCATCAAATCATGTGCCAGCTTATGCTAAAGAACTTTTTTATAATATTCAATTGGAGGGACTTCAACCTATTTTGGTCCACCCTGAGCGTAATAGTGGAATCATTGAGAACCCGGATATATTATTTGATTTTATTGAACAAGGAGTACTAAGTCAGATAACAGCTTCGAGTGTCACTGGTCATTTTGGTAAAAAAATACAAAAGCTGTCATTTAAAATGATAGAAAACCATCTGACGCATTTTGTTGCATCAGATGCGCATAATGTGACGTCACGTGCATTTAAGATGAAGGAGGCATTTGAAATGATTGAAGAAAGTTGTGGTTCTGATGTATCACAAATATTTCAAAATAACGCAAGGTCAGTGATTTTAAACGAAAGTTTTTATCAAGAAAAACCAACAAAGATCAAAACAAAAAAATTTTTAGGATTATTTTAA	MIDIHCHILPGIDDGAKTSGDTLTMLKSAIDEGITTITATPHHNPQFNNESPLILKKVKEVQNIIDEHQLPIEVLPGQEVRIYGDLLKEFSEGKLLTAAGTSSYILIEFPSNHVPAYAKELFYNIQLEGLQPILVHPERNSGIIENPDILFDFIEQGVLSQITASSVTGHFGKKIQKLSFKMIENHLTHFVASDAHNVTSRAFKMKEAFEMIEESCGSDVSQIFQNNARSVILNESFYQEKPTKIKTKKFLGLF	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	36.29	gnl|BL_ORD_ID|4745|hsp_num:0	1983			1554	1671	vancomycin
BGC0000764.1|Exopolysaccharide_11 # 6073 # 6759 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.362	BGC0000764.1|Exopolysaccharide_11 	6073	6759	+	Loose	400	25.0238	IMP-81	30.23	3005486	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGGAAGTTTTTGAGGATGTCTCATCACATGAACCGGAAGAGCATAAGTTAGTAGAATTAAAAAAATTTTCTCATAGAGAGATAATTATAAAAAGAGGGATTGATATTTTAGGGGGATTAGCGGGTTCAGTTTTATTTCTTATTGCGGCTGCATTGCTTTATGTCCCTTACAAAATGAGCTCGGAAAAAGATCAAGGGCCAATGTTCTATAAACAAAAACGGTATGGAAAAAACGGTAAAATTTTTTATATTTTGAAATTTAGAACAATGATAATTAATGCTGAGCATTATCTAGAGCTCCATCCAGAAATTAAAGCTGCCTACCATGCCAATGGCAACAAATTAGAAAATGATCCACGGGTAACGAAGATTGGGTCATTTATCAGACGACACTCAATTGATGAGTTACCACAATTTATCAATGTTCTTAAAGGGGATATGGCATTGGTTGGCCCAAGACCAATTTTGCTTTTTGAAGCGAAAGAATATGGGGAGCGCCTCTCTTACTTACTCATGTGTAAACCTGGAATTACTGGTTATTGGACAACACATGGTCGAAGTAAAGTTCTTTTTCCTCAACGAGCAGATTTAGAACTCTATTACCTCCAGTACCATAGCACCAAAAACGATATCAAGCTTCTATCACTCACAATTGTACAAAGTATTAACGGATCGGACGCATATTAA	MEVFEDVSSHEPEEHKLVELKKFSHREIIIKRGIDILGGLAGSVLFLIAAALLYVPYKMSSEKDQGPMFYKQKRYGKNGKIFYILKFRTMIINAEHYLELHPEIKAAYHANGNKLENDPRVTKIGSFIRRHSIDELPQFINVLKGDMALVGPRPILLFEAKEYGERLSYLLMCKPGITGYWTTHGRSKVLFPQRADLELYYLQYHSTKNDIKLLSLTIVQSINGSDAY	MSKLFVFCMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTDAYLIDTPFTAKDTEKLVTWFVERGYKIKGSVSSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGVSYWLVKNKVEIFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLMSKYGKAKLVVPSHSEVGDASLLKLTLVQAVKGLNESKKPSKPSN	92.68	gnl|BL_ORD_ID|3637|hsp_num:0	4706			606	702	
BGC0000764.1|Exopolysaccharide_12 # 6763 # 7212 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.316	BGC0000764.1|Exopolysaccharide_12 	6763	7212	+	Loose	1000	25.409	Clostridium perfringens mprF	32.0	3003773	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAAAATAGCATTAGTAGGTTCCAGCGGTGGCCATTTGACACACCTGTATTTGTTAAAAAAGTTTTGGGAAAACGAAGATAGATTTTGGGTCACATTTGATAAAACAGATGCAAAATCTATATTGAAAGGAGAAAGATTTTATCCTTGTTATTATCCCACAAATAGAAATGTAAAAAACACGATAAAAAATACTATTCTTGCATTTAAAATACTTAGAAAAGAAAAACCAGATTTGATTATTTCGAGTGGTGCTGCGGTAGCCGTTCCTTTTTTCTGGATAGGTAAACTATTCGGTGCAAAAACAATCTATATTGAAATATTTGACCGGATTGATAAACCAACCTTAACAGGAAAATTAGTTTATCCAGTTACTGATAAGTTTATAGTTCAATGGGAAGAGTTAAAAAAAGTCTATCCTAAAGCGATTAATCTAGGAGGGATTTTCTAA	MKIALVGSSGGHLTHLYLLKKFWENEDRFWVTFDKTDAKSILKGERFYPCYYPTNRNVKNTIKNTILAFKILRKEKPDLIISSGAAVAVPFFWIGKLFGAKTIYIEIFDRIDKPTLTGKLVYPVTDKFIVQWEELKKVYPKAINLGGIF	MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK	26.19	gnl|BL_ORD_ID|2058|hsp_num:0	2282			762	912	defensin
BGC0000764.1|Exopolysaccharide_13 # 7212 # 7697 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.327	BGC0000764.1|Exopolysaccharide_13 	7212	7697	+	Loose	350	25.7942	AAC(2')-Id	24.64	3002526	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGATTTTTGTAACTGTTGGAACTCACGAACAACCATTTAATCGACTCATTCAAAAAATTGATGAACTTGTACGTGACGGTCAAATAAAAGATGATGTATTCATGCAAATTGGTTACTCGACTTATGAGCCAAAATATACAAAATGGGCGTCAGTGATAGGGTATAATGATATGACTGCATATTTTAATAAAGCAGACATCGTGATTACACACGGAGGTCCTTCAACCTATATGCAAGTTTTACAACATGGTAAGATTCCAATTGTAGTACCACGGCAAGAAAAGTTTGGTGAACATATTAACGATCACCAATTACGGGTAAGTAAACAAGTGATTAAAAAGGGATATCCTCTTATATTGTGCGAAGATGTCTCAGCTTTGAAGATTTGTATTGAAAGTTCAAGGATTAGAACAGATGAATTTATTAAAAGCAACAATAAGAATTTTATATCAAATTTTAAAAAAATAATAGCTTCCGAGGAATGA	MIFVTVGTHEQPFNRLIQKIDELVRDGQIKDDVFMQIGYSTYEPKYTKWASVIGYNDMTAYFNKADIVITHGGPSTYMQVLQHGKIPIVVPRQEKFGEHINDHQLRVSKQVIKKGYPLILCEDVSALKICIESSRIRTDEFIKSNNKNFISNFKKIIASEE	MLTQHVSEARTRGAIHTARLIHTSDLDQETRDGARRMVIEAFRDPSGDSDFTDDFTDDDWDHALGGMHALISHHGALIAHGAVVQRRLMYRGPDGRGHALRCGYVEAVAVREDRRGDGLGTAVLDALEQVIRGAYQIGALSASDIARPMYIARGWLSWEGPTSVLTPTEGIVRTPEDDRSLFVLPVDLPDGLELDTAREITCDWRSGDPW	76.67	gnl|BL_ORD_ID|1297|hsp_num:0	1415			198	405	dibekacin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; gentamicin
BGC0000764.1|Exopolysaccharide_14 # 7697 # 8260 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.291	BGC0000764.1|Exopolysaccharide_14 	7697	8260	+	Loose	550	29.6462	PmrF	25.0	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAAAATTTAAAATTAGTGTAATATTAAGAACTTATAATGAAGTTAAACATATTGGTGAAGTTCTTAAAAGTTTAACAGAACAGACATATTTAAACCATGAAATTATTATAGTTGATTCTGGTTCAGTGGATGGAACCTTAGATATAATAGAGCGGTATCCAGTAAAACTTGTATCAATTAATAAAGAAGACTTTAATTATAGTTATGCTTCAAATGTTGGTGTTCAAAACTCCTCAGGGGATATTGTATGTTTTTTGAGTGGACATTCGGTGCCAGTTTATAAAAATTACCTTGAAAAAATAAATGAGATTTTTCAAGAAACTGAGATAGGTGCTTGTTATGGAGAAGTGATTGCCTTACCAGATGGAAGCATTACGGAAAAGATATTTAATAGAATAGGTTATCTAAAAAGTAAGTTAAGTCTCAATAATAAAAGATTTTTTTTAGAAAATAAAATTCATCCAGGTATATTTTCAGTTGTAGTAATGCTTGCGCCAGAAAGAAATTATTACTTAAATACCCTTTTAAAGTCGAACTCGGTCATGGAGGTGAAGATGTAG	MKKFKISVILRTYNEVKHIGEVLKSLTEQTYLNHEIIIVDSGSVDGTLDIIERYPVKLVSINKEDFNYSYASNVGVQNSSGDIVCFLSGHSVPVYKNYLEKINEIFQETEIGACYGEVIALPDGSITEKIFNRIGYLKSKLSLNNKRFFLENKIHPGIFSVVVMLAPERNYYLNTLLKSNSVMEVKM	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	58.07	gnl|BL_ORD_ID|1937|hsp_num:0	2014			24	303	polymyxin B
BGC0000764.1|Exopolysaccharide_15 # 8263 # 8436 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGGAG(G)/GGAGG;rbs_spacer=13-15bp;gc_cont=0.264	BGC0000764.1|Exopolysaccharide_15 	8263	8436	+	Loose	500	22.3274	mphE	48.0	3003741	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGGCTTATAGAATTATTCAAGATGGATATTTTGTAGCAAAATCAGTTGAATTGCTCGTAATGCATTCTCACGGAAGTTCATTAAAAAAATTTATAAAGGAATATAAAGCTTGGGGTAAAATGTATGAAGATGTCCTAAATTTTATTAAAAAAAATAATGACAAATATCAATAG	MAYRIIQDGYFVAKSVELLVMHSHGSSLKKFIKEYKAWGKMYEDVLNFIKKNNDKYQ	MTIQDIQSLAEAHGLLLTDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKEKRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITSLAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDNDVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKTLIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGVI	19.39	gnl|BL_ORD_ID|2687|hsp_num:0	2614			708	783	erythromycin
BGC0000764.1|Exopolysaccharide_16 # 8420 # 9574 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.258	BGC0000764.1|Exopolysaccharide_16 	8420	9574	+	Loose	850	26.5646	abeM	29.58	3000753	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGACAAATATCAATAGAAAAAAATTTTTGATAAATTTTCAAAGTTTGGTTTTTTTCATATTAATAATTATTTACGGGCTAACTACAAAAAATGTCATGGGAGGATCAGGTATCTTTTCAATTGATAGCATATTAAAATATGGTATCTTATTTATTTGTATTAGTGTAGAAGGGTATATATTCCTAAAAAACGGAAATGAAAAAAGGGAAACTTCTGAAAATTACAATAATTTTAAGTTTTATTTTATTATAATCACTTTTTTATCTCTTTTTGCTTCTTTTAAACAAGTACATTTTAGTTTCAGAACGGTCCAATCTTTTATATTTATTTTTATTCCTATGTTATATTCATATCTAATCTTAAATAATTGGACTTTTAGACAGATCAATTTTTCAATGAAGATAGCATTATTCTTATCAGTTATAGAGTATTTATTCTCAATTAGGATGGGTTTTTCTCAGATTATCAGCAGTCTAGCTTCAATAAATTACAATAATACAAATGCTTCACCATTAGAATCCTCAACCTTTGCACTCCTATCATTAGGATTTGTTGCTTATTTTGGATATTATAAGAAAAATTTTTTATGTAAAATAGTTAGTTTGCTATTTGTTATTATGACATTTAAAAGAGTTATTACTCTAGGTGGTTGTATTTTGGTTATTTTAGGTATACTTAAAATTAAAAATCTTAGGGTTAATAGGTTTTTTTTGATAGTTTCAACAATTACATTGGTGTCATTTTCATTAATTTATTATTATTCAATTCAACCCCAAAATATATTAGAAATCAGTGAAAAAATAGGCTTCAGTATTAGAGATTTTTCAACAAATCGTACAGATAGGTTAGCTTGGTTAAGTATGACTGATTTTAAAAGTTATGGTCTTGGCTCCACTACTGACTTTATGTATAAGTTATGGGGTGTTGATTTAGAAATGGATATTGTACAACTTATTTTAGAAGTTGGTGCCTTTGGAGTAATTGTTTTTATATATTTTTATCTTAGATTTTCAAAAAGCAACCTATATGCGTTCTCATTTATGGCCTTATTGTTACTAAACTCAATATTGTCATCGGGTATGATGTCAACTTTTTCTTGGATAATAATTTTAATTGCAATGAGTACCATTATGGAATATAAAGAAGGAATGTAG	MTNINRKKFLINFQSLVFFILIIIYGLTTKNVMGGSGIFSIDSILKYGILFICISVEGYIFLKNGNEKRETSENYNNFKFYFIIITFLSLFASFKQVHFSFRTVQSFIFIFIPMLYSYLILNNWTFRQINFSMKIALFLSVIEYLFSIRMGFSQIISSLASINYNNTNASPLESSTFALLSLGFVAYFGYYKKNFLCKIVSLLFVIMTFKRVITLGGCILVILGILKIKNLRVNRFFLIVSTITLVSFSLIYYYSIQPQNILEISEKIGFSIRDFSTNRTDRLAWLSMTDFKSYGLGSTTDFMYKLWGVDLEMDIVQLILEVGAFGVIVFIYFYLRFSKSNLYAFSFMALLLLNSILSSGMMSTFSWIIILIAMSTIMEYKEGM	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	85.71	gnl|BL_ORD_ID|1254|hsp_num:0	1368			474	672	ciprofloxacin; acriflavine; norfloxacin; ofloxacin; triclosan
BGC0000764.1|Exopolysaccharide_17 # 9579 # 9728 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.233	BGC0000764.1|Exopolysaccharide_17 	9579	9728	+	Loose	550	31.187	PmrF	32.56	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAAATAAATTTAGTATAATTGTTCCTGTATATAATGGGGAAAGTCATATAAAAAAATGTATAGATACTCTATTAAAGCAGACTTATAATGATTTTGAAATTATTATTATTAATGATGGGTCTACGATGACACTAAGTCAGTTTTAA	MKNKFSIIVPVYNGESHIKKCIDTLLKQTYNDFEIIIINDGSTMTLSQF	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	15.22	gnl|BL_ORD_ID|1937|hsp_num:0	2014			24	153	polymyxin B
BGC0000764.1|Exopolysaccharide_20 # 11680 # 12630 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.266	BGC0000764.1|Exopolysaccharide_20 	11680	12630	+	Loose	550	33.4982	PmrF	23.66	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGATCGCAAATCAAATCTCCCACTTGTATCGATTATAATAACAACATTTAATAGGATTAATTATCTTAAACAAATGCTTGAGAGCATACTAATTCAATCTTATAAAAATGTAGAAATTATTATTGTTGATGATGGATCAGTAGATAATACTAAAAATATTATAAGAGAATATCAACTAAAGTATAAACAACAAATAATTTTTTTTGAAGGTAAGAAAGGGCCAGGAATAAATAGATTTTTAGCATATCAAAAGATTTCAGGAGAGTTTATTGTATTTTGTGACGATGATGATTACTATACCGACATTAATTTTATTGAAAAAAGTGTAAATATCATGTATAACTTCCAAGATGTTTCTCTAATTTGCTTCAGTTCCGACATTTTATATGTTAAAGATAATTTACTTGAAACAAAACAATTAAATAAAAAAGGTATTTTTGAGAGCGGAGAAGTTGCAAACAATTTTTTAACTGAGTTTCAAAAACCTAATAGTACTTTTCCTTCCTTTTACAGAAGAAGTACATTTGAGAAAAATGGTTTTACTGAAGTTAAAAGCTTTAATGATACAAACATTTATCTAAGAGGAATTTTAGGTGGGAAGGTATATTATTCCCAAAAAAATGTTGGTGTTTATCGAGTTCATTCAGGGTCTATAGGTAATTCATTGGATCCTAATTTTATTATTCAAGTACTGAATGAAAAAAAAATTTTAAGCAAGTATTTAATGACTTCCCCCAAAAAGCAAGAACAATGGCTTTATCTTCAAACACTTAATACAACAGATTACTATGCTGATAGAAGTAGCAAAGTGGAATACTTTACCATACTAAAATGGTTTAAATTAAATTTAAGCAACAACTATTACCACAGAGCAAAAAAGATGTTCATTTTTGCAAGAATCAAATTTCTAATGAAGAAATTTATAAAGAGAAAAAATCCATATATATAG	MDRKSNLPLVSIIITTFNRINYLKQMLESILIQSYKNVEIIIVDDGSVDNTKNIIREYQLKYKQQIIFFEGKKGPGINRFLAYQKISGEFIVFCDDDDYYTDINFIEKSVNIMYNFQDVSLICFSSDILYVKDNLLETKQLNKKGIFESGEVANNFLTEFQKPNSTFPSFYRRSTFEKNGFTEVKSFNDTNIYLRGILGGKVYYSQKNVGVYRVHSGSIGNSLDPNFIIQVLNEKKILSKYLMTSPKKQEQWLYLQTLNTTDYYADRSSKVEYFTILKWFKLNLSNNYYHRAKKMFIFARIKFLMKKFIKRKNPYI	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	98.14	gnl|BL_ORD_ID|1937|hsp_num:0	2014			27	306	polymyxin B
BGC0000764.1|Exopolysaccharide_21 # 12779 # 14227 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.274	BGC0000764.1|Exopolysaccharide_21 	12779	14227	+	Loose	350	27.7202	BcIII	28.57	3007101	protein homolog model	n/a	n/a	cephalosporin; penem	antibiotic inactivation	class A Bacillus cereus Bc beta-lactamase	ATGAAAAAAGTTGGCCATAATTATATCCTAAATTTACTTTATCAGTTATTAATGGTTATTCTCCCGTTAATAACTGCACCATATATTTCTAGAACTATAGGAGCGGAAGGGATCGGGATAAATGCATTTACAGCTACAATTGCACAGTATTTTGTTATTGTAGCTGTTCTTGGCACTGCGACTTATGGAAATAGAGAAATTGCATATCATCAGAATGATAAGGAAGCGAGAAGTCAAATTTTTTGGGGTATTACATTTGTTAGTTGGATATCTGCTACGATTGCTCTTGTGTCTTATATAATAGTTATTACTTTTTTGAAGAGTTACCATACAATATATTTATTGCAGGGTTTATTAATTTTGACCTCTTTATTTGATATTTCTTGGTATTTTATGGGAAGAGAAAACTTTCGAGTTATAGTGTTTAGAAATTTCTTGATAAAAATTATCACTCTCATTTGTATACTTATTTTTATTAAAACTCCTTTAGATTTAACTAAATATGTAGCTATAAGTACAATTGGCGGGTTTTTGGGTAGTTTATCATTATGGCCCTATTTAAGAAAAGAAATATTTAAACCAAAATTCAAGGCACTTAATTTAAGTGTACATTTTAAATATACACTAGCACTATTCTTACCACAAATTATGATGCAAGTATATACAATTCTAAATAGAAATATGATCGGTGCCTTTGACTCTATTAGAAACTTAGGATACTACAACCAAGCAGATACTTTGATTAAAGCAGTATTATCAGTTATAACAGCTTTTAGTCCAGTAATGCTTCCACATATTGCAAAAATGCATGCTCAAAATCAAAAAAAAAGAGTCAAGGAACTTATAGTAAAATCATTTAATATCATTTCAGGCTTAAGTATTGCACTATTTTTTGGATTAGCAGGGATTGCATTAAACTTTGCTCCTTTTTTTTGGGGGGAAGACTTCATCAAGGTAGGTATATTAATATTTGTACAATCACCCTTTCTAATATTCATTAGTTGGAATTATATAATAGGCGGCCAATACCTATTGGCGACAAATAAAATCAAAATTTATTCAACATCAATTATTATTGCAGCAATAGTGAGCTTAATTACAAATTTGATACTAATTCCTACTATTGGAGTGGTTGGTGCATCAATATCGGCAATTCTTTCGGAGTTTTCAATATTTATATATCAGAGATATAACACAAAAGAAGATTTTTCAAATAAAGAATTATTTAATCAAATATGGAAGTATTTACTATCTGGATTAATTATGTTCATTATTATATTTGAGATAAATCAAACATTTAAAATGAATGTTGTACAACTAATATTGCAAGTATTTTTAGGAGCAATAATATATATTTTTATGAATTTTGTTTTGAAAACAAAATTATGGGAATATTTTTATAGTTTACTTTTTAAAATTATATTTAAAAATTTTAAAAAGAATTTATAA	MKKVGHNYILNLLYQLLMVILPLITAPYISRTIGAEGIGINAFTATIAQYFVIVAVLGTATYGNREIAYHQNDKEARSQIFWGITFVSWISATIALVSYIIVITFLKSYHTIYLLQGLLILTSLFDISWYFMGRENFRVIVFRNFLIKIITLICILIFIKTPLDLTKYVAISTIGGFLGSLSLWPYLRKEIFKPKFKALNLSVHFKYTLALFLPQIMMQVYTILNRNMIGAFDSIRNLGYYNQADTLIKAVLSVITAFSPVMLPHIAKMHAQNQKKRVKELIVKSFNIISGLSIALFFGLAGIALNFAPFFWGEDFIKVGILIFVQSPFLIFISWNYIIGGQYLLATNKIKIYSTSIIIAAIVSLITNLILIPTIGVVGASISAILSEFSIFIYQRYNTKEDFSNKELFNQIWKYLLSGLIMFIIIFEINQTFKMNVVQLILQVFLGAIIYIFMNFVLKTKLWEYFYSLLFKIIFKNFKKNL	MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFAKLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGDTVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTGNKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK	152.53	gnl|BL_ORD_ID|4780|hsp_num:0	5775			144	270	
BGC0000764.1|Exopolysaccharide_22 # 14483 # 14641 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.226	BGC0000764.1|Exopolysaccharide_22 	14483	14641	+	Loose	500	23.8682	BUT-2	37.93	3005558	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	BUT beta-lactamase	ATGTGCTATAATACTTTATTAGCTGATCTAGTGTTTATTAAAAGATTCATAATTATATTGGGAAAAAATATTAGTATAAAATTATCAGATATGCTGCTTGACGATGAAATGAATTATGAAAATTTCAAACTAATTAATTTAAAACACTGGTTGAACTAA	MCYNTLLADLVFIKRFIIILGKNISIKLSDMLLDDEMNYENFKLINLKHWLN	MMKKTLCCALVLSASFSAFAAQKTLSDKQLEEAVNQTLKPMITAQAIPGMAVAVIYQGKPHYFTYGVADIAKNQPVTTQTIFELGSVSKTFTGVLGGDIVARGEVKLSDPAMKYWPELTGKQWQGITLLDLATYTAGGLPLQVPDEVDNQAALLKFYQNWQPDWAPGTRRQYANSSIGLFGALAVKPSGMTFNDAMRQRVLQPLNLKHTWLTVPASEENHYAWGYRDGKAMHVGPGMLDTEAYGVKSTIEDMASWVQYNMNPQQVKQPTLQKGLEIAQSRYWRSGSMYQGLGWEMLNWPVAAATVINGSDNKVALAASPVTAIEPPVAPVKASLVHKTGSTNGFGAYVAFIPEKQIGIVMLANKMYPNTERVKAANTLLNTLQ	13.58	gnl|BL_ORD_ID|3338|hsp_num:0	4407			546	633	
BGC0000764.1|Exopolysaccharide_23 # 14834 # 15736 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.346	BGC0000764.1|Exopolysaccharide_23 	14834	15736	+	Loose	400	27.335	catP	29.63	3002686	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGAACGAAAAAAGAAGAAGAAAGAGAATATTTGGGCAATAATTGTACCTATCTTAATAATAATTTCCCTTATAGGAGCATGGGCTTATGCCTTAAGAGATTCACTTATTCCTACTGATTATACAAAAACAAACAGCTCGGATCAACCGACCAAAACTTCGGTTTCTAACGGTTATGTAGAACAAAAAGGTGAAGAAGCTGCTGTGGGTAGTATAGCACTTGTAGATGATGCTGGTGTACCAGAATGGGTTAAAGTTCCCTCAAAGGTAAATCTAGATAAATTTACTGATTTATCTACGAATAATATCACTATTTATCGAATTAACAATCCGGAAGTCTTAAAAACAGTTACCAATCGTACGGATCAACGGATGAAAATGTCAGAAGTTATAGCTAAGTATCCTAATGCTTTGATTATGAATGCTTCCGCATTTGATATGCAGACAGGACAAGTAGCTGGATTTCAAATTAATAATGGAAAGTTGATTCAAGACTGGAGTCCAGGTACAACGACTCAATATGCTTTTGTTATTAACAAAGATGGTTCGTGCAAAATTTATGATTCAAGTACACCTGCTTCAACTATTATTAAAAACGGAGGGCAACAAGCCTATGATTTTGGTACTGCAATTATCCGTGATGGTAAAATTCAACCAAGTGATGGCTCAGTAGATTGGAAGATCCATATTTTTATTGCGAATGATAAAGATAATAATCTCTATGCTATTTTGAGTGATACAAATGCAGGTTATGATAATATAATGAAATCAGTGTCAAATTTGAAGCTCCAAAATATGTTATTACTTGATAGTGGTGGTTCAAGTCAACTATCTGTCAATGGTAAAACGATTGTTGCTAGTCAAGATGATCGAGCCGTACCGGATTATATTGTGATGAAATAA	MERKKKKKENIWAIIVPILIIISLIGAWAYALRDSLIPTDYTKTNSSDQPTKTSVSNGYVEQKGEEAAVGSIALVDDAGVPEWVKVPSKVNLDKFTDLSTNNITIYRINNPEVLKTVTNRTDQRMKMSEVIAKYPNALIMNASAFDMQTGQVAGFQINNGKLIQDWSPGTTTQYAFVINKDGSCKIYDSSTPASTIIKNGGQQAYDFGTAIIRDGKIQPSDGSVDWKIHIFIANDKDNNLYAILSDTNAGYDNIMKSVSNLKLQNMLLLDSGGSSQLSVNGKTIVASQDDRAVPDYIVMK	MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQIKEKGMKLYPAMLYYIAMIVNRHSEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYGNNHRMEGKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKEDNKIILPLAIQVHHAVCDGFHICRFVNELQELINS	144.93	gnl|BL_ORD_ID|429|hsp_num:0	477			183	345	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000764.1|Exopolysaccharide_24 # 15761 # 16663 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.322	BGC0000764.1|Exopolysaccharide_24 	15761	16663	-	Loose	500	27.7202	OXA-143	27.2	3001654	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAATCAAAAAAAGAGGCGTCATTATCGTAAGAAAAAACACACAGTACTAAAAGTTATTTCAATTATTTTTGTATTAGTAATTATCGCTGTTGCTTCTATAGCCTACGCCGCTTATAGAAATGTTGAATCAACATTTTCAACATCATATGAAAATTTCCCTAAAACAACAAGTATTGACTTAAAAAAGTCTAAAACATTCACCACACTTATCATTGCAACTGGTAAAAATAATTCTAAAAATACAGCTTATGCTACTGTTTTAGCTTCAACGAATGTAAAGACAAATCAAACTACTTTCATGAACTTCCCAGTTTTTGCGACAATGCCTAATCAAAAAACAATCACTGAAGTTTACAATACGAATGGAGATGATGGAATTTTCCAGATGGTTAAAGACCTATTGAATGTGTCCATTAACAAAGTAATTCAGATCGATGTTAATAAAATGGGATCACTTGTACAGGCCTCTGGTGGAATCACCATGCAAAATCCAAAGGCATTCAATGCTGAAGGTTATGAGTTTAAACAAGGAACTGTTAATTTACAAACTGCTGATCAAGTCCAAGCCTATATGACACAAATTGATGATACTGATTTGGATGCTTCAATCACTCGGATTCAAAATGTCTCAATGGAACTCTACGGAAATATTCAAAAAATTGCTCATATGAAAAAACTTGAAAGTTTCAATTACTATCGAGAAATTCTCTATGCTTTTTCAAACACTGTTAAAACCAATATAAGTTTCAATGATGCTAAAACGATCGTTATGAGCTACAATAAGGCTCTAAAGAATACCAGCAAGCTCAATCTACATACAACAGATGAAAATGGAGCTAAGGTAGTTTCTCAAACAGAATTAGACTCAGTCAAAATCCTTTTTGAAAAATCTCTAAAATAA	MNQKKRRHYRKKKHTVLKVISIIFVLVIIAVASIAYAAYRNVESTFSTSYENFPKTTSIDLKKSKTFTTLIIATGKNNSKNTAYATVLASTNVKTNQTTFMNFPVFATMPNQKTITEVYNTNGDDGIFQMVKDLLNVSINKVIQIDVNKMGSLVQASGGITMQNPKAFNAEGYEFKQGTVNLQTADQVQAYMTQIDDTDLDASITRIQNVSMELYGNIQKIAHMKKLESFNYYREILYAFSNTVKTNISFNDAKTIVMSYNKALKNTSKLNLHTTDENGAKVVSQTELDSVKILFEKSLK	MKKFILPILSISTLLSVSACSSIQTKFEDTFHTSNQQHEKAIKSYFDEAQTQGVIIIKKGKNISTYGNNLTRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMTLGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEVNFADDFANNRLPFKLETQEEVKKMLLIKEFNGSKIYAKSGWGMDVTPQVGWLTGWVEKSNGEKVAFSLNIEMKQGMPGSIRNEITYKSLENLGII	109.09	gnl|BL_ORD_ID|282|hsp_num:0	313			3	357	cloxacillin; oxacillin; cefalotin
